This opportunity is no longer accepting applications.
grant

Notice of Special Interest (NOSI): Pre-Clinical Research on Gene Therapies for Rare Genetic Neurodevelopmental Disorders

NOT-MH-23-236

The NIMH is supporting research to develop and test technologies and methods for creating gene therapies aimed at treating rare neurodevelopmental disorders. This involves different gene therapy approaches like replacing, adding, editing, or silencing genes. The goal is to gather preclinical data using cell or animal experiments to evaluate the safety and effectiveness of these potential treat…

The NIMH is encouraging research to establish, optimize, and evaluate technologies and assays needed for the clinical development of somatic cell gene therapies to treat rare neurodevelopmental disorders. This includes gene replacement, addition, editing, and silencing. The focus is on obtaining…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Mental Health

Dates

Opportunity Released: April 28, 2023

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.